Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study
Low‐molecular‐weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study
复制标题
DOI：
10.1111/j.1365-2036.2006.02870.x
复制
发表时间：
2006-05
影响因子：
7.6
通讯作者：
P. Zezos;G. Papaioannou;N. Nikolaidis;K. Patsiaoura;A. Papageorgiou;T. Vassiliadis;O. Giouleme;N. Evgenidis
中科院分区：
文献类型：
--
作者：
P. Zezos;G. Papaioannou;N. Nikolaidis;K. Patsiaoura;A. Papageorgiou;T. Vassiliadis;O. Giouleme;N. Evgenidis
Heparin could be beneficial to the treatment of active ulcerative colitis because of its anticoagulant, anti‐inflammatory and immunomodulatory properties.
